Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A Rodan

Showing results (11-20 of 200) with videos related to

Pageof 20
Sort By:
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Alendronate: preclinical studiesG A Rodan
Biochemical and Biophysical Research Communications|October 15, 1986
Type-beta transforming growth factor inhibits proliferation and expression of alkaline phosphatase in murine osteoblast-like cellsM Noda, G A Rodan
The Journal of Cell Biology|February 1, 1989
Transcriptional regulation of osteopontin production in rat osteoblast-like cells by parathyroid hormoneM Noda, G A Rodan
International Journal of Clinical Practice. Supplement|April 3, 2003
Preclinical safety profile of alendronateC Peter, G A Rodan
Annals of Medicine|August 1, 1993
Bisphosphonates in the treatment of metabolic bone diseasesG A Rodan, R Balena
Connective Tissue Research|January 1, 1989
Type beta transforming growth factor regulates expression of genes encoding bone matrix proteinsM Noda, G A Rodan
Journal of Cellular Physiology|December 1, 1987
Type beta transforming growth factor (TGF beta) regulation of alkaline phosphatase expression and other phenotype-related mRNAs in osteoblastic rat osteosarcoma cellsM Noda, G A Rodan
Endocrinology|August 1, 1990
Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3M Ernst, G A Rodan
Cell|May 30, 1997
The missing boneG A Rodan, S Harada
Molecular Endocrinology (Baltimore, Md.)|August 1, 1991
Estradiol regulation of insulin-like growth factor-I expression in osteoblastic cells: evidence for transcriptional controlM Ernst, G A Rodan
Pageof 20

Showing results (11-20 of 200) with videos related to

Sort By:
Pageof 20
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Alendronate: preclinical studiesG A Rodan
Biochemical and Biophysical Research Communications|October 15, 1986
Type-beta transforming growth factor inhibits proliferation and expression of alkaline phosphatase in murine osteoblast-like cellsM Noda, G A Rodan
The Journal of Cell Biology|February 1, 1989
Transcriptional regulation of osteopontin production in rat osteoblast-like cells by parathyroid hormoneM Noda, G A Rodan
International Journal of Clinical Practice. Supplement|April 3, 2003
Preclinical safety profile of alendronateC Peter, G A Rodan
Annals of Medicine|August 1, 1993
Bisphosphonates in the treatment of metabolic bone diseasesG A Rodan, R Balena
Connective Tissue Research|January 1, 1989
Type beta transforming growth factor regulates expression of genes encoding bone matrix proteinsM Noda, G A Rodan
Journal of Cellular Physiology|December 1, 1987
Type beta transforming growth factor (TGF beta) regulation of alkaline phosphatase expression and other phenotype-related mRNAs in osteoblastic rat osteosarcoma cellsM Noda, G A Rodan
Endocrinology|August 1, 1990
Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3M Ernst, G A Rodan
Cell|May 30, 1997
The missing boneG A Rodan, S Harada
Molecular Endocrinology (Baltimore, Md.)|August 1, 1991
Estradiol regulation of insulin-like growth factor-I expression in osteoblastic cells: evidence for transcriptional controlM Ernst, G A Rodan
Pageof 20